Breeze Meds vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

Willow beats Breeze Meds overall, scoring 7.5/10 vs 7.3/10. Breeze Meds is more affordable at $199/mo vs $299/mo. Choose Breeze Meds for users who want to order compounded glp-1s month-by-month wit. Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side look at Breeze Meds and Willow to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Breeze Meds

#33 of 52

7.3/10

Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.

Visit Breeze Meds

Higher Rated

Willow

#24 of 52

7.5/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	Breeze Meds	Willow
Our Score	7.3/10	7.5/10
Starting Price	$199/mo	$299/mo
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	Users who want to order compounded GLP-1s month-by-month with no subscription commitment	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking	#33	#24
Get started	Visit Breeze Meds	Visit Willow

Pros & Cons Compared

Breeze Meds

Pros

+No subscription required, order on demand without recurring billing commitments
+Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
+FSA/HSA eligible for those with health savings accounts
+Discreet packaging on all shipments

Cons

−Independent reviews are very limited and the company structure is unclear, so legitimacy is hard to verify. Ask for pharmacy details first; the no-subscription model at least keeps a first order low-commitment.
−Oral options at $299-399/mo cost significantly more than injectable alternatives. The $199 injectable semaglutide is the value pick unless tablets are a must.
−Not available in all 50 states; availability depends on provider licensure, so check your state early in the online visit.

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide, one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only, no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
−Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024, less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Breeze Meds with a score of 7.5/10 vs 7.3/10. If budget is your priority, Breeze Meds starts at $199/mo compared to Willow's $299/mo. Choose Breeze Meds if you want: users who want to order compounded glp-1s month-by-month with no subscription commitment. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Breeze Meds nor Willow feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review